Dosing | SPEVIGO® (spesolimab-sbzo)

Two forms of SPEVIGO tailored to your treatment needs

Icon of a syringe representing SPEVIGO SC monthly treatment for GPP

SPEVIGO SC

A monthly treatment (injection) that may be taken at home to help reduce the risk of a GPP flare (your doctor will show you how)

IV bag icon representing Spevigo IV infusion treatment

SPEVIGO IV

A different form given at an infusion center or hospital to treat an active GPP flare

While SPEVIGO IV is a proven way to treat an active flare, continuous treatment (SPEVIGO SC) is important to help control ongoing GPP inflammation and reduce the risk of a future flare. Talk to your doctor about the right care plan for your journey.

Get to know SPEVIGO SC

Starting SPEVIGO SC

Here’s what to expect if your doctor prescribes SPEVIGO SC to help reduce the risk of a GPP flare:

This is not all the information needed to receive SPEVIGO. Please review the full Instructions for Use before starting treatment.

600mg loading dose for month 1. 300mg in month 2. 300mg in month 3 and on,

Understanding your dose

When you start treatment with SPEVIGO SC, your doctor may give you a higher dose of this medicine, called a loading dose,* which is given to quickly build up levels of SPEVIGO in your body.

You will take SPEVIGO SC every 4 weeks.

Always use SPEVIGO exactly as your doctor prescribes.

*A loading dose may not be required if you recently received SPEVIGO IV for the
treatment of a flare.

Learning how to inject SPEVIGO

Before starting SPEVIGO SC injections at home, your doctor will confirm it’s appropriate for you and will show you how to inject. This video can be a helpful reminder of the steps for injecting a single prefilled syringe.

To deliver a complete dose of SPEVIGO, you must inject the full contents of all syringes included in the carton of medicine you receive. The steps for taking your medicine are the same, regardless of how many syringes you receive. If your carton contains a second prefilled syringe, repeat these steps for the second injection.

This video is provided for educational purposes only and is not intended to replace discussions with your doctor.

Please review the full Instructions for Use before starting treatment.

Helpful resources

Review step-by-step
instructions to inject SPEVIGO

Injection guide.

Print a placemat
to help organize your supplies

Self-injection placemat.

SPEVIGO should not be administered if you or your child have had a severe or life-threatening allergic reaction to spesolimab-sbzo or any of the ingredients in SPEVIGO.

Get to know SPEVIGO IV

This is not all the information needed to receive SPEVIGO. Please review the full Instructions for Use before starting treatment.

Receiving SPEVIGO IV

Here’s what to expect if your doctor prescribes SPEVIGO IV to extinguish an active GPP flare:

This is not all the information needed to receive SPEVIGO. Please review the full Instructions for Use before starting treatment.

What happens at a SPEVIGO infusion

To help you feel more comfortable on treatment day, this video explains the typical experience of receiving SPEVIGO IV.

This video is provided for educational purposes only and is not intended to replace discussions with your doctor.

Helpful resources

Get answers to common
questions about infusions

Infusion guide.

Let healthcare teams
know you have GPP

GPP ID card.

SPEVIGO should not be administered if you or your child have had a severe or life-threatening allergic reaction to spesolimab-sbzo or any of the ingredients in SPEVIGO.

GPP=generalized pustular psoriasis.
IV=intravenous.
SC=subcutaneous.

Connect with us to find helpful information, answers to your questions, and explore financial support

GO

Indication

SPEVIGO is a prescription medicine used to treat generalized pustular psoriasis (GPP) in adults and children 12 years of age and older who weigh at least 88 pounds (40 kg). It is not known if SPEVIGO is safe and effective in children under 12 years of age or who weigh less than 88 pounds (40 kg).

Please see the full Prescribing Information, including Medication Guide and Instructions for Use.

Important Safety Information
and Indication

Do not receive SPEVIGO if you or your child have had a severe or life-threatening allergic reaction to spesolimab-sbzo or any of the ingredients in SPEVIGO.

SPEVIGO may cause serious side effects, including:

Infections: SPEVIGO may lower the ability of your or your child’s immune system to fight infections and may increase your or your child’s risk of infections. Your healthcare provider should check you or your child for infections and tuberculosis (TB) before starting treatment with SPEVIGO and may treat you or your child for TB before you begin treatment with SPEVIGO if you have a history of TB or have active TB. Your healthcare provider should watch you or your child closely for signs and symptoms of TB during or after treatment with SPEVIGO. Tell your healthcare provider right away if you or your child have an infection or have symptoms of an infection during or after treatment with SPEVIGO, including, fevers, chills, or sweats, muscle aches, cough, shortness of breath, blood in your phlegm (mucus), burning when you urinate, urinating more often than normal
Allergic reactions and infusion-related reactions: Serious allergic reactions may happen during or after your or your child’s SPEVIGO injection. If you or your child have a serious allergic reaction, your healthcare provider will stop treatment with SPEVIGO. If you or your child are given SPEVIGO in a vein (intravenously) and have an infusion-related reaction, your healthcare provider will stop your or your child’s SPEVIGO infusion and treat your or your child’s symptoms and may restart SPEVIGO at a slower infusion rate. Tell your healthcare provider or get emergency medical help right away if you or your child get any of the following symptoms during or after your or your child’s SPEVIGO injection: feeling faint, dizzy, or lightheaded, swelling of your face, eyelids, lips, mouth, tongue, or throat, trouble breathing or throat tightness, fever, mouth sores, chest tightness, hives or skin rash that is different than the rash from generalized pustular psoriasis (GPP), itching, swollen lymph nodes

Before you or your child receive SPEVIGO, tell your healthcare provider about all of your medical conditions, including if you or your child:

have an infection that does not go away or that keeps coming back.
have TB or have been in close contact with someone with TB.
have recently received or are scheduled to receive an immunization (vaccine). You or your child should not receive live vaccines during and for at least 16 weeks after treatment with SPEVIGO. You or your child should be brought up to date with all vaccines before starting SPEVIGO.
are pregnant or plan to become pregnant. It is not known if SPEVIGO can harm your or your child’s unborn baby.
are breastfeeding or plan to breastfeed. It is not known if SPEVIGO passes into your breast milk. Talk to your healthcare provider about the best way to feed your or your child’s baby during treatment with SPEVIGO.

The most common side effects of SPEVIGO given in a vein (intravenously) for GPP flare treatment include feeling tired or weak, headache, nausea, itching or itchy bumps, a collection of blood under the skin at the infusion site or bruising, urinary tract infection

The most common side effects of SPEVIGO when given under the skin (subcutaneously) for treatment of GPP when not experiencing a flare include redness, pain, swelling, hardening, hives, or warmth at the injection site, joint pain, urinary tract infection, itching

These are not all of the possible side effects of SPEVIGO. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Please see the full Prescribing Information, including Medication Guide and Instructions for Use.

Read more Collapse